Valeant (VRX) announces management appointments that will take place once the company closes its...

|About: Valeant Pharmaceuticals I... (VRX)|By:, SA News Editor

Valeant (VRX) announces management appointments that will take place once the company closes its acquisition of Medicis (MRX), which it expects on Dec 11. Ray Weldon, who's been at Valeant since 2008, will lead its U.S. Dermatology operations while Medicis COO Jason Hanson will lead certain U.S and international businesses and functions.